Общедоступные статьи - Su-Hyun KimПодробнее...
2 статьи недоступны нигде
Asian and African/Caribbean AQP4-NMOSD patient outcomes according to self-identified race and place of residence
R Soares-dos-Reis, JL Tsz-Ching, SH Kim, A Jacob, D Whittam, ...
Multiple Sclerosis and Related Disorders 53, 103080, 2021
Финансирование: National Natural Science Foundation of China, National Medical Research …
Hierarchical multimodal fusion of deep-learned lesion and tissue integrity features in brain mris for distinguishing neuromyelitis optica from multiple sclerosis
Y Yoo, LYW Tang, SH Kim, HJ Kim, LE Lee, DKB Li, S Kolind, ...
Medical Image Computing and Computer Assisted Intervention− MICCAI 2017 …, 2017
Финансирование: Natural Sciences and Engineering Research Council of Canada
11 статей доступны в некоторых источниках
Myelin-oligodendrocyte glycoprotein antibody-associated disease
R Marignier, Y Hacohen, A Cobo-Calvo, AK Pröbstel, O Aktas, ...
The Lancet Neurology 20 (9), 762-772, 2021
Финансирование: US National Institutes of Health, National Institute for Health Research, UK …
Racial differences in neuromyelitis optica spectrum disorder
SH Kim, MA Mealy, M Levy, F Schmidt, K Ruprecht, F Paul, M Ringelstein, ...
Neurology 91 (22), e2089-e2099, 2018
Финансирование: German Research Foundation
Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases
JW Hyun, MR Woodhall, SH Kim, IH Jeong, B Kong, G Kim, Y Kim, ...
Journal of Neurology, Neurosurgery & Psychiatry 88 (10), 811-817, 2017
Финансирование: Wellcome Trust
Serum glial fibrillary acidic protein: a neuromyelitis optica spectrum disorder biomarker
O Aktas, MA Smith, WA Rees, JL Bennett, D She, E Katz, BAC Cree, ...
Annals of neurology 89 (5), 895-910, 2021
Финансирование: US National Institutes of Health
Association of maintenance intravenous immunoglobulin with prevention of relapse in adult myelin Oligodendrocyte glycoprotein antibody–associated disease
JJ Chen, S Huda, Y Hacohen, M Levy, I Lotan, A Wilf-Yarkoni, ...
JAMA neurology 79 (5), 518-525, 2022
Финансирование: US National Institutes of Health, Government of Spain
Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion …
MA Mealy, SE Mossburg, SH Kim, S Messina, N Borisow, ...
Multiple sclerosis and related disorders 28, 64-68, 2019
Финансирование: US National Institutes of Health
Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders
MA Mealy, SH Kim, F Schmidt, R López, JA Jimenez Arango, F Paul, ...
Multiple Sclerosis Journal 24 (13), 1737-1742, 2018
Финансирование: US National Institutes of Health
Longitudinal retinal changes in MOGAD
FC Oertel, ES Sotirchos, HG Zimmermann, S Motamedi, S Specovius, ...
Annals of Neurology 92 (3), 476-485, 2022
Финансирование: Federal Ministry of Education and Research, Germany
Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis
JW Hyun, SY Huh, HJ Shin, M Woodhall, SH Kim, SR Irani, SH Lee, ...
Multiple Sclerosis Journal 25 (4), 585-590, 2019
Финансирование: Wellcome Trust
Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases
Y Kim, JW Hyun, MR Woodhall, YM Oh, JE Lee, JY Jung, SY Kim, MY Lee, ...
Multiple Sclerosis and Related Disorders 40, 101939, 2020
Финансирование: Wellcome Trust
Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo …
JL Bennett, O Aktas, WA Rees, MA Smith, M Gunsior, L Yan, D She, ...
EBioMedicine 86, 2022
Финансирование: US National Institutes of Health
Информация о публикациях и финансировании собрана автоматически.